分類彙整:王長怡

PharmaBoardRoom interview of Dr. Chang Yi Wang, Chairperson and Chief Scientific Officer of United Biopharma (UBP)

United Biomedical, Inc. (UBI) is dedicated to the discovery, development, and commercialization of immunotherapies & vaccines for chronic and infectious diseases and is passionate about delivering science-driven innovation with platform capabilities. 繼續閱讀

發表於 Chang Yi Wang, 人物側寫, 公司新聞, 專家筆記, 王長怡, 王長怡博士演講, 生醫新知 | 發表迴響

英國著名PharmaBoardRoom媒體記者、訪問聯生藥董事長暨科學長 王長怡博士

聯合生物醫學集團 (UBI)是一致力於發現、開發和商業化用於慢性和感染性疾病的免疫治療藥品和疫苗,並熱衷於以平台技術提供科學驅動創新的公司。王長怡乃UBI旗下子公司之一的聯合生物製藥(United BioPharma,UBP)董事長兼首席科學長,而UBP正是她所創立的UBI集團的其中一企業。她談論了她令人驚豔的事業生涯,包括從1973年身為首位被美國洛克菲勒大學錄取的亞洲女性博士生,到有機緣受數位諾貝爾獎得主指導或與共事而被薰陶訓練,以及她如何利用研究和管理經驗在年輕時即創立UBI公司,及她在重要領域中堅持在公司內部建立自主生產技術背後的思維。 繼續閱讀

發表於 人物側寫, 公司新聞, 專家筆記, 王長怡, 王長怡博士演講, 生醫新知, 產業訊息, 社會經濟 | 發表迴響

王長怡

王長怡(英文名: Chang Yi Wang ),王長怡博士為一位全球知名華人女科学家(免疫学權威)、发明家、跨國生物醫藥集團企業聯合生物醫學公司(United Biomedical Inc., UBI)創辦人暨董事長,她被媒體授予「台湾生技業傑出企業領袖」的稱號,被譽為台灣生技業標竿領導者。 繼續閱讀

發表於 人物側寫, 專家筆記, 王長怡, 王長怡博士演講 | 發表迴響

Chang Yi Wang

Chang Yi Wang (traditional Chinese: 王長怡; simplified Chinese: 王长怡) is the founder of United Biomedical, Inc. (UBI) , headquartered in Hauppauge, New York, and its group of companies in Asia. 繼續閱讀

發表於 Chang Yi Wang, 人物側寫, 專家筆記, 王長怡, 王長怡博士演講 | 發表迴響

Introduction to Dr. Chang Yi Wang

Introduction to Dr. Chang Yi Wang 繼續閱讀

發表於 Chang Yi Wang, 人物側寫, 專家筆記, 王長怡, 王長怡博士演講 | 發表迴響

Introduction to UBP Chairwoman Dr. Wang ChangYi

United BioPharma (UBP), a spinoff company of UBI Asia, was founded by Dr. Chang Yi Wang. Dr. Wang serves as the executive Chairwoman of the Board of Directors and Chief Scientific Officer of UBP. At the invitation of the Taiwanese government in 1998, Dr. Wang set out to establish UBI-Asia, a joint venture between United Biomedical, Inc. (UBI) based in the US and the Taiwan government. She launched a state-of-the-art protein and antibody drug development platform within UBI Asia employing monoclonal antibody B4 as a touch stone and built a competent team with integrated platform technologies to enable development of antibody products from DNA to BLA filings. Other antibody and long acting protein products followed, leading to the spinoff of United Biopharma with a group of rigorously selected antibody products. 繼續閱讀

發表於 人物側寫, 專家筆記, 王長怡, 王長怡博士演講 | 發表迴響

Introduction to Dr. Chang Yi Wang – Founder and Chief Scientific Officer of UBI Group of Companies

Introduction to Dr. Chang Yi Wang – Founder and Chief Scientific Officer of UBI Group of Companies 繼續閱讀

發表於 Chang Yi Wang, 人物側寫, 專家筆記, 王長怡, 王長怡博士演講 | 發表迴響

生技界女杰 — 台湾联亚生技开发董事长王长怡 — 华商名人堂 — 华商名人堂专稿

王长怡是首个荣获“美国年度发明家奖”的华裔女科学家,也是台湾生技业领军者。 繼續閱讀

發表於 人物側寫, 公司新聞, 王長怡, 生醫新知, 社會經濟 | 發表迴響

Interview part one: Chang Yi Wang, Chairperson & CEO, UBI Asia, and Chairperson & CSO, UBI

In the first of this two-part interview, the chairperson of UBI and UBI Asia explains the work that her company has done to improve the landscape for Taiwanese pharma and biotech companies over the last fifteen years, and goes in-depth into the company’s innovative pipeline, including UBI’s possible HIV cure. To read the second part of this interview, click here. 繼續閱讀

發表於 Chang Yi Wang, 人物側寫, 專家筆記, 王長怡, 王長怡博士演講, 生醫新知, 社會經濟 | 發表迴響

Interview part two: Chang Yi Wang, Chairperson & CEO, UBI Asia, and Chairperson & CSO, UBI

In the second part of this two-part interview, the Chairperson of UBI and UBI Asia offers her thoughts on the challenges and opportunities of the Chinese market, and explains her own personal history that led her to the creation of the company. To read the first part of this interview, click here. 繼續閱讀

發表於 Chang Yi Wang, 人物側寫, 專家筆記, 王長怡, 王長怡博士演講, 社會經濟 | 發表迴響